Related Experiment Video
Updated: Aug 7, 2026
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis
A M Namboodiri1, K M Rocca, M Kuwana
1Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425-2230, USA.
Objective:
To determine whether elevated levels of antibodies to HCMV protein UL83 were present in patients with SSc and if their prevalence was associated with major SSc-associated autoantibodies.
Methods:
The study population consisted of 253 Caucasian subjects (110 SSc patients and 143 controls). IgG antibodies to UL83 were measured by an enzyme-linked immunosorbent assay (ELISA). Antibodies to centromere and RNA polymerase (RNAP) were determined by indirect immunofluorescence and immnoprecipitation methods, respectively.
Results:
The mean level of anti-UL83 antibodies in the sera of SSc patients as a whole was significantly higher than that in control subjects (14.75 vs 10.6 units/microl, p = 0.002). Both subgroups of patients contributed to this variation: compared to controls, anti-UL83 antibody levels were higher in diffuse (16.32 vs 10.6 units/microl, p = 0.012) as well as in those with the limited form of the disease (13.95 vs 10.6 units/microl, p = 0.015). Anti-UL83 antibodies were not associated with major SSc associated autoantibodies.
Conclusion:
Humoral immunity to HCMV protein UL83 may be relevant to the etiopathogenesis of scleroderma.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
